Skip to Content

L48 (Darifenacin Hydrobromide Extended-Release 7.5 mg)

Pill with imprint L48 is White, Round and has been identified as Darifenacin Hydrobromide Extended-Release 7.5 mg. It is supplied by Macleods Pharmaceuticals Limited.

Darifenacin is used in the treatment of overactive bladder; urinary incontinence and belongs to the drug class urinary antispasmodics. Risk cannot be ruled out during pregnancy. Darifenacin 7.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for L48

Darifenacin Hydrobromide Extended-Release

Imprint:
L48
Strength:
7.5 mg
Color:
White
Shape:
Round
Availability:
Prescription only
Drug Class:
Urinary antispasmodics
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Macleods Pharmaceuticals Limited
Manufacturer:
Macleods Pharmaceuticals Limited
National Drug Code (NDC):
33342-0276

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide